xRead - Olfactory Disorders (September 2023)
20426984, 2022, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.22929, Wiley Online Library on [04/09/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
364
INTERNATIONAL CONSENSUS ON OLFACTION
TABLE VII.4 (Continued) Study
Year LOE Study design Study groups
Clinical end point
Conclusions
Klimek et al
2017 4
Case series
47 patients with persistent AR
SS-TDI
Mean baseline TDI score of the cohort was 23.7 ( ± 3.9), consistent with hyposmia ( ≤ 30.5). intraseasonally, both patients with perennial and seasonal AR exhibited OD as compared with controls Extraseasonally, only odor threshold testing was significantly lower in patients with seasonal AR as compared with controls Odor discrimination and identification similar in AR and control patients preseasonally, but odor thresholds decreased in the AR group Intraseasonal testing revealed OD in the AR group, which correlated with nasal eosinophilic cation protein levels OD existed in > 50%of patients with AR for ≥ 10 years OD exists extraseasonally in patients with AR for ≥ 10 years Patients with non-AR exhibited a significantly lower TDI score consistent with greater OD as compared with patients with AR or mixed rhinitis 50% of patients with AR exhibited hyposmia. No significant difference between patients with CRS in addition to AR. Patients with non-AR had a lower UPSIT R score ( P = 0.06). Of 17 patients with AR, 12 exhibited mild to moderate OD at baseline, 2 were anosmic, and 3 had normal OF (Continues) When tested
Moll et al
1998 4
Case-control
28 patients with seasonal AR 47 patients with perennial AR Control group: 66 healthy patients
CCCRC olfactory test
CCCRC olfactory test NVF Eosinophilic cation protein levels
Klimekand Eggers
1997 4
Case-control
17 patients with AR (grass pollen) Control group: 12 healthy patients
Suzuki et al
2018 4
Case-control
50 control patients 50 patients with AR for < 10years 50 patients with AR for ≥ 10years AR: 50 patients Non-AR: 40 patients Mixed rhinitis: 32 patients
Odor identification (Open Essence test)
Odor detection Odor threshold
SS-TDI
La Mantia et al
2018 4
Case-control
Guss et al
2009 4
Case-control
31 patients with AR 10 patients with AR + CRS 10 patients with non-AR
UPSIT R CTsinus Allergy Prick Testing
Nasal symptoms UPSIT R Histopathology
Sivamet al
2010 2
RCT
Placebo control group: 9 patients with AR Mometasone treatment group: 8 patients with AR
examination of OE
Made with FlippingBook flipbook maker